skip to main content

    Updated Visitor Guidelines

 

MENU

 

Breast Cancer

Wall Street Journal: Chemotherapy 'falls out of favor'

The Wall Street Journal looks at efforts to improve how oncologists determine which patients need chemotherapy. What once was a crucial part of cancer treatment might now be best avoided for some patients at low risk. The article cites research from U-M Rogel Cancer Center member Steven Katz, M.D., MPH.

Breast Cancer Recurrence Risk Continues Years After Treatment

Even 20 years after a diagnosis, women with a type of breast cancer fueled by estrogen still face a substantial risk of cancer returning or spreading, according to a new analysis from an international team of investigators published in the New England Journal of Medicine.

New Device Tracks Which Cancer Cells Cause Metastasis

As cancer grows, it evolves. Individual cells become more aggressive, break away to flow through the body and spread to distant areas. What if there were a way to find those early aggressors? How are they different from the rest of the cells? And more importantly: Is there a way to stop them before they spread?

Precision Medicine Test for Breast Cancer Helps Guide Chemotherapy Decisions

A new study finds doctors are appropriately using a genetic test to measure breast cancer recurrence risk and to make tailored treatment recommendations.

The Future of Breast Cancer Research

University of Michigan Rogel Cancer Center breast cancer researchers discuss the amazing progress of breast cancer research over the past decades and look ahead to the day when it's understood exactly how and why breast cancer spreads so it can be stopped.

Double Mastectomy May Lead to Missed Work

Women who pursue a more aggressive surgery for early stage breast cancer have nearly eight times the odds of reporting substantial employment disruptions, according to a new study from University of Michigan Rogel Cancer Center researchers.

Expanding Cancer Research in Ethiopia

To understand cervical cancer in Ethiopia, U-M’s Rozek has developed a new screening and survey of women. She hopes to compare it with results from other countries in Asia and the Middle East.

What a Plastic Surgeon Wants You to Know About Breast Reconstruction

Women undergoing a mastectomy for breast cancer already have a lot to manage in regard to treatment and recovery. Beyond monitoring their health, they must also weigh a decision that could alter their appearance and quality of life after cancer treatment: whether to have breast reconstruction surgery -- and, if they do, which type to choose. The procedure can have physical and mental implications for patients whose cancerous breasts are surgically removed. Opting for reconstructive surgery after a mastectomy comes with questions and choices. A U-M plastic surgeon helps address them.

New Compound Shows Potential for Triple-Negative Breast Cancer

An investigation from the University of Michigan could eventually lead to new therapies that take aim at the most aggressive type of breast cancer -- triple-negative.

Pages